BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

195 hedge funds and large institutions have $1.65B invested in BioCryst Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 36 closing their positions.

Holders
195
Holders Change
+4
Holders Change %
+2.09%
% of All Funds
3.4%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
41
Increased
61
Reduced
61
Closed
36
Calls
$81.8M
Puts
$68.5M
Net Calls
+$13.3M
Net Calls Change
-$610K

Top Buyers

1
Fisher Asset Management
1
Fisher Asset Management
Washington
$31.8M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$29.3M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$16.3M
4
BCPEMI
4
Bain Capital Public Equity Management II
Massachusetts
$24.7M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$13.8M

Top Sellers

1
SCM
1
Sarissa Capital Management
Connecticut
$67.4M
2
HM
2
HealthCor Management
New York
$51.4M
3
Goldman Sachs
3
Goldman Sachs
New York
$12.8M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$0
5
State Street
5
State Street
Massachusetts
$98.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$12.8M -$21.5M -1,360,428 -63%
Assenagon Asset Management
27
Assenagon Asset Management
Luxembourg
$11.9M +$11.2M +710,563 +1,598%
Invesco
28
Invesco
Georgia
$11.9M -$10.8M -681,726 -48%
Federated Hermes
29
Federated Hermes
Pennsylvania
$11.8M +$11.4M +722,057 +2,898%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$11.7M +$370K +23,412 +3%
CS
31
Credit Suisse
Switzerland
$11.3M +$7.59M +479,982 +203%
Millennium Management
32
Millennium Management
New York
$11.3M +$11.3M +715,140 New
PHS
33
PFM Health Sciences
California
$11.2M +$11.2M +708,927 New
Two Sigma Advisers
34
Two Sigma Advisers
New York
$11.2M +$7.65M +483,900 +216%
Victory Capital Management
35
Victory Capital Management
Texas
$10.3M -$500K -31,655 -5%
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$9.05M +$9.05M +572,378 New
CM
37
Caption Management
Oklahoma
$7.98M +$7.98M +505,000 New
GIM
38
Granahan Investment Management
Massachusetts
$7.18M +$381K +24,093 +6%
NSIM
39
North Star Investment Management
Illinois
$6.9M +$14.2K +900 +0.2%
Osaic Holdings
40
Osaic Holdings
Arizona
$6.58M +$429K +27,148 +7%
Swiss National Bank
41
Swiss National Bank
Switzerland
$6.16M -$215K -13,600 -3%
PHP
42
Parkman Healthcare Partners
Connecticut
$5.57M +$1.7M +107,281 +44%
First Trust Advisors
43
First Trust Advisors
Illinois
$5.48M +$5.48M +346,833 New
LCG
44
Lisanti Capital Growth
New York
$5.41M -$2.06M -130,335 -28%
GGHC
45
Gilder Gagnon Howe & Co
New York
$4.96M +$1.61M +101,986 +48%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$4.8M +$582K +36,843 +14%
Citigroup
47
Citigroup
New York
$4.77M -$954K -60,351 -17%
BIA
48
Biondo Investment Advisors
Pennsylvania
$4.2M +$4.2M +265,840 New
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$4.11M -$145K -9,200 -3%
EI
50
EAM Investors
California
$3.95M +$3.95M +249,856 New
1
2
3 4 5